Literature DB >> 3036285

Role of monocytes in the inhibitory effect of calcitriol on PHA-stimulated lymphocytes.

M T Zarrabeitia, J A Riancho, V Rodriguez-Valverde, M C Farinas, J Gonzalez-Macias.   

Abstract

The possible role played by monocytes in the inhibitory effect of calcitriol on phytohemagglutinin (PHA)-stimulated lymphocyte proliferation was assessed by testing the effect of this sterol under different cell culture conditions. Calcitriol had a dose-dependent inhibitory effect on lymphocyte proliferation in concentrations ranging from 10(-10) up to 10(-8) M. The effect of 10(-9) M calcitriol was almost completely abolished by: a) monocyte depletion, b) inhibition of prostaglandin (PG) synthesis by indomethacin, and c) addition of exogenous interleukin-2 (IL-2). These results suggested that the inhibitory effect of calcitriol was mediated through monocytes. This possibility was substantiated by the following observations: a) the calcitriol inhibitory effect was restored when autologous adherent cells were added to monocyte-depleted PBM cells; b) the supernatant of adherent cells cultured for 24 hours in the presence of calcitriol exerted a marked inhibitory effect on lymphocyte proliferation; and c) this effect was not longer evident when adherent cells were cultured in the presence of calcitriol plus indomethacin. These data support the hypothesis that calcitriol acts, at least partially, through the monocytes, inducing an increased release of PG, with subsequent inhibition of IL-2 synthesis, then resulting in a decreased lymphocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036285     DOI: 10.1007/BF00626015

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  11 in total

1.  Prostaglandins as endogenous mediators of interleukin 1 production.

Authors:  S L Kunkel; S W Chensue; S H Phan
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

Review 2.  The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins).

Authors:  A W Norman; J Roth; L Orci
Journal:  Endocr Rev       Date:  1982       Impact factor: 19.871

Review 3.  Interleukin 1 and T cell activation.

Authors:  S B Mizel
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

4.  Further characterization of the human autologous mixed leukocyte reaction (MLR).

Authors:  R P MacDermott; M C Stacey
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

5.  Constitutive secretion of interleukin 1 by human monocytes.

Authors:  A J Treves; V Barak; T Tal; Z Fuks
Journal:  Eur J Immunol       Date:  1983-08       Impact factor: 5.532

6.  1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro.

Authors:  J M Lemire; J S Adams; V Kermani-Arab; A C Bakke; R Sakai; S C Jordan
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

7.  Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol).

Authors:  W F Rigby; T Stacy; M W Fanger
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

8.  1,25-dihydroxyvitamin D3 receptors in human leukocytes.

Authors:  D M Provvedini; C D Tsoukas; L J Deftos; S C Manolagas
Journal:  Science       Date:  1983-09-16       Impact factor: 47.728

9.  Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation.

Authors:  A K Bhalla; E P Amento; T L Clemens; M F Holick; S M Krane
Journal:  J Clin Endocrinol Metab       Date:  1983-12       Impact factor: 5.958

10.  Prostaglandin E inhibits the production of human interleukin 2.

Authors:  R S Rappaport; G R Dodge
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

View more
  1 in total

1.  Comparison of cellular and transcriptional responses to 1,25-dihydroxyvitamin d3 and glucocorticoids in peripheral blood mononuclear cells.

Authors:  Sonia S Kupfer; Joseph C Maranville; Shaneen S Baxter; Yong Huang; Anna Di Rienzo
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.